Date:2/9/2009

====== ===== BECKMAN COULTER, INC. SEGMENT REVENUES (1) (in millions) (unaudited) Quarter Ended December 31, Constant ------------ Reported Currency 2008 2007 Growth % Growth %(2) ---- ---- -------- ----------- Clinical Diagnostics: Chemistry and Clinical Automation $229.7 $229.9 (0.1)% 3.5% Cellular Analysis 245.1 235.2 4.2% 8.0% Immunoassay and Molecular Diagnostics 190.5 166.0 14.8% 18.5% ----- ----- Total Clinical Diagnostics 665.3 631.1 5.4% 9.1% Life Sciences 146.0 158.0 (7.6)% (3.7)% ----- ----- Total revenues $811.3 $789.0 2.8% 6.6% ====== ====== Year Ended December 31, Constant ------------ Reported Currency 2008 2007 Growth % Growth %(2) ---- ---- -------- ----------- Clinical Diagnostics: Chemistry and Clinical Automation $898.6 $815.3 10.2% 8.4% Cellular Analysis 954.2 840.9 13.5% 11.7% Immunoassay and Molecular Diagnostics 739.1 627.2 17.9% 15.7%
'/>"/>

SOURCE Beckman Coulter - IR Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards